首页> 外国专利> Therapy with baclofen and acamprosate for Alzheimer's disease in patients who have lost their responsiveness to acetylcholinesterase inhibitor therapy

Therapy with baclofen and acamprosate for Alzheimer's disease in patients who have lost their responsiveness to acetylcholinesterase inhibitor therapy

机译:在对乙酰胆碱酯酶抑制剂治疗失去反应性的患者中,用Baclofen和Amamprosate进行阿尔茨海默病治疗

摘要

The present invention is for the treatment of Alzheimer's disease or Alzheimer-related disorders in patients who do not respond to an acetylcholinesterase inhibitor, typically in patients who have been treated with an acetylcholinesterase inhibitor and have lost their responsiveness to the acetylcholinesterase inhibitor. With respect to combinations and methods using baclofen and acetylcholinester. [Selection diagram] None
机译:本发明用于治疗阿尔茨海默病或与阿尔茨海默氏症相关的疾病,其患者不响应乙酰胆碱酯酶抑制剂,通常用于用乙酰胆碱酯酶抑制剂处理的患者,并且已经失去对乙酰胆碱酯酶抑制剂的反应性。关于使用Baclofen和乙酰胆碱的组合和方法。 [选择图]无

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号